Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 6/20 | 1.00 |
| ▸ | GRIN3B | O60391 | 6/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 6/20 | 1.00 |
| ▸ | GRIN2A | Q12879 | 6/20 | 1.00 |
| ▸ | GRIN2B | Q13224 | 6/20 | 1.00 |
| ▸ | GRIN2C | Q14957 | 6/20 | 1.00 |
| ▸ | GRIN3A | Q8TCU5 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.45 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | STAT6 | P42226 | 1/20 | 0.45 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7001522 | 1.00 | GRIN2D (1.00) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Bromide SCHEMBL8385913 | 0.97 | GRIN2D (0.94) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Hydrochloric Acid SCHEMBL3027022 | 0.97 | GRIN2D (0.94) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Bromide SCHEMBL8385911 | 0.94 | GRIN2D (0.89) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL17065128 | 0.87 | — | — | |
| SCHEMBL15314277 | 0.86 | GRIN2D (0.75) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Sulfuric Acid SCHEMBL15210964 | 0.85 | GRIN2D (0.73) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL3717250 | 0.82 | GRIN2D (0.70) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL22564421 | 0.82 | GRIN2D (0.68) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL25618694 | 0.82 | GRIN2D (0.68) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011687-A | High-toughness epoxy resin-based carbon fiber prepreg and preparation method thereof | 江苏美伦新材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| US-20250361545-A1 | LABEL, MARKER AND METHOD FOR ANALYZING A BIOLOGICAL SAMPLE | LEICA MICROSYSTEMS (DE) | 2025-11-27 | — | — | US | claimed |
| US-20250362289-A1 | LABEL, MARKER AND METHOD FOR ANALYZING A BIOLOGICAL SAMPLE | LEICA MICROSYSTEMS (DE) | 2025-11-27 | — | — | US | claimed |
| EP-4653544-A1 | A LABEL, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE | Leica Microsystems CMS GmbH (DE) | 2025-11-26 | — | — | EP | claimed |
| EP-4653543-A1 | A LABEL, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE | Leica Microsystems CMS GmbH (DE) | 2025-11-26 | — | — | EP | claimed |
| US-12472271-B2 | HDAC6 inhibitors and imaging agents | THE GENERAL HOSPITAL CORPORATION (US) | 2025-11-18 | — | — | US | claimed |
| US-12460126-B2 | Quantum dot, method of preparing the quantum dot, composition including the quantum dot, optical member including the quantum dot, and electronic apparatus including the quantum dot | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-11-04 | — | — | US | claimed |
| CN-120131975-A | Host-guest fucoidin carrier, preparation method and application thereof, fucoidin nanocrystalline delivery system, preparation method and application thereof, pharmaceutical composition and application thereof | 石河子大学第一附属医院 | 2025-06-13 | — | — | CN | claimed |
| EP-4565233-A1 | TREATMENT FOR APLASTIC ANEMIA (AA) | Zydus Lifesciences Limited (IN) | 2025-06-11 | — | — | EP | claimed |
| US-5932566-A | Ansamycin derivatives as antioncogene and anticancer agents | PFIZER INC. (US) | 1999-08-03 | — | — | US | claimed |
| EP-0863877-A4 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TORREY PINES INST (US) | 1999-07-21 | — | — | EP | claimed |
| US-5916899-A | SOLID PHASE SYNTHESIS, REACTING PROTECTED AMINO ACID WITH SOLID SUPPORT; FORMING IMINE BY REACTION WITH ALDEHYDE, CYCLIZATION WITH ANHYDRIDE, CLEAVAGE AND DEPROTECTION. | TREGA BIOSCIENCES, INC. (US) | 1999-06-29 | — | — | US | claimed |
| US-5874443-A | BIOSYNTHESIS | TREGA BIOSCIENCES, INC. (US) | 1999-02-23 | — | — | US | claimed |
| EP-0863877-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1998-09-16 | — | — | EP | claimed |
| WO-1997016428-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1997-05-09 | — | — | WO | claimed |
| EP-0706516-A1 | ANSAMYCIN DERIVATIVES AS ANTIONCOGENE AND ANTICANCER AGENTS | PFIZER INC. (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1995001342-A1 | ANSAMYCIN DERIVATIVES AS ANTIONCOGENE AND ANTICANCER AGENTS | PFIZER INC. (US) | 1995-01-12 | — | — | WO | claimed |
| US-4894180-A | Liquid crystal optical element | FUJI PHOTO FILM CO., LTD. (JP) | 1990-01-16 | — | — | US | claimed |
| US-3941885-A | N-ADAMANTANYL AMINO ALKANOIC ACID | SCHERING CORPORATION (US) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12472271-B2 | HDAC6 inhibitors and imaging agents | HDAC1, HDAC6, HDAC11 | GRIN2D 1068/4885GRIN3B 499/4885GRIN1 390/4885 |
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | SSB, GRN, ALB | GRIN2D 3179/4885GRIN3B 1681/4885GRIN1 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.